Related Experiment Video
Updated: Jun 2, 2026

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
Methylphenidate-induced visual hallucinations
M C Porfirio1, G Giana, S Giovinazzo
1Department of Neuroscience, Child Neurology Unit, Tor Vergata University, Rome, Italy.
Abstract:
An 11-year-old boy with attention deficit/hyperactivity disorder (ADHD) presented with visual hallucinations several years after starting methylphenidate (MPH). The hallucinations resolved upon discontinuation of the drug. Reports of toxic hallucinosis during treatment with MPH are rare. Although the pathogenetic mechanism is unclear, the occurrence of hallucinations may be explained by a chronic increase in synaptic dopamine. Clinicians should be aware of this possible rare adverse manifestation occurring at therapeutic doses.
Insights
Visual hallucinations are a rare side effect of methylphenidate (MPH) treatment for attention deficit/hyperactivity disorder (ADHD). This case highlights the importance of considering MPH as a potential cause for hallucinations in pediatric patients.
Area of Science:
- Neuroscience
- Pharmacology
- Pediatrics
Background:
- Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children.
- Methylphenidate (MPH) is a widely prescribed stimulant medication for managing ADHD symptoms.
- Stimulant medications like MPH primarily work by increasing dopamine and norepinephrine levels in the brain.
Observation:
- An 11-year-old boy diagnosed with ADHD experienced visual hallucinations.
- These hallucinations emerged several years into his treatment with MPH.
- The visual hallucinations ceased after MPH was discontinued.
Findings:
- This case report documents a rare instance of toxic hallucinosis associated with therapeutic MPH doses.
- The proposed mechanism involves a potential chronic increase in synaptic dopamine levels.
- Hallucinations are an uncommon but possible adverse effect of MPH treatment.
Implications:
- Clinicians prescribing MPH for ADHD should be vigilant for potential visual hallucinations.
- Discontinuation of MPH may lead to the resolution of drug-induced hallucinations.
- Further research into the neurobiological mechanisms underlying MPH-induced hallucinations is warranted.
Related Concept Videos
CNS Stimulants: Psychedelic Agents
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Positive Symptoms Schizophrenia: Hallucinations and Delusions
Hallucinations
Hallucinations in...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain that...

